|
|
|
|
|||||
|
|
|
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the top low volatility healthcare stocks to buy now. On July 24, Barclays analyst Luke Sergott raised the firm’s price target on Thermo Fisher Scientific Inc. (NYSE:TMO) to $490 from $450, keeping an Equal Weight rating on the shares.
The analyst told investors in a research note that Thermo Fisher Scientific Inc. (NYSE:TMO) reported a Q2 beat, with Q2 revenue rising 3% to $10.85 billion. GAAP diluted earnings per share for the quarter grew 6% to $4.28, while adjusted EPS reached $5.36.
Thermo Fisher Scientific Inc. (NYSE:TMO) provides analytical instruments, reagents, equipment, software, and other services for analysis, research, diagnostics, and discovery.
It operates through the Analytical Instruments, Life Sciences Solutions, Laboratory Products and Services, and Specialty Diagnostics segments.
While we acknowledge the potential of TMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
| 2 hours | |
| Jul-28 | |
| Jul-28 | |
| Jul-28 | |
| Jul-28 | |
| Jul-28 | |
| Jul-28 | |
| Jul-28 | |
| Jul-26 | |
| Jul-25 | |
| Jul-25 | |
| Jul-24 | |
| Jul-24 | |
| Jul-24 | |
| Jul-24 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite